Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Direct | Direct |
| Fund house | UTI | Axis |
| NAV | ₹11.8098 | ₹21.1061 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 1.8 years | 4.7 years |
| Expense ratio | 0.8% | 0.4% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 57.80 |
Returns
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| 1 month | +4.58% | +4.51% |
| 3 months | −0.77% | +0.06% |
| 6 months | +1.92% | +12.76% |
| YTD | +8.48% | +15.40% |
| 1 year | +3.90% | +13.12% |
| 3 years (CAGR) | — | +15.26% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +11.73% | +17.40% |
Risk
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| Volatility | — | 21.9% |
| Downside volatility | — | 13.4% |
| Sharpe | — | 0.40 |
| Sortino | — | 0.65 |
| Calmar | — | 0.61 |
| Return / risk | — | 0.70 |
| Deepest fall | −17.37% | −27.74% |
| Days to recover | 65 | 380 |
| Below its high | −2.05% | −1.48% |
Against benchmark
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| Best 1-year | +15.28% | +80.07% |
| Middle 1-year | +4.38% | +13.12% |
| Worst 1-year | −4.59% | −17.32% |
| 1-year periods with a loss | 15.0% | 17.4% |
| Middle 3-year | — | +24.12% |
| Positive months | — | 58.3% |
| Best day | +4.36% | +4.79% |
| Worst day | −3.80% | −7.47% |
| Worst 5% day | −1.93% | −2.24% |
| Positive days | 53.6% | 55.5% |
| NAVs a year | 247 | 251 |
SIP of ₹10,000 a month
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | +11.96% |
| 1-year XIRR | +10.31% | +21.81% |
Holdings overlap i
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund Direct · filing Oct 2026 | — | 17% |
| Axis Nifty Smallcap 50 Index Fund Direct · filing Oct 2026 | 17% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund |
|---|---|---|
| Welspun Corp Limited | 2.05% | 3.70% |
| Sona Blw Precision Forgings Limited | 1.92% | 4.83% |
| Acutaas Chemicals Limited | 1.90% | 2.51% |
| Anand Rathi Wealth Limited | 1.66% | 2.48% |
| Karur Vysya Bank Limited | 1.41% | 4.06% |
| Gland Pharma Limited | 1.27% | 2.98% |
| Central Depository Services (India) Limited | 0.80% | 2.71% |
| Great Eastern Shipping Co Limited | 0.80% | 1.91% |
| Computer Age Management Services Limited | 0.78% | 1.90% |
| Neuland Laboratories Limited | 0.77% | 2.05% |
| Angel One Limited | 0.76% | 2.22% |
| City Union Bank Limited | 0.67% | 2.49% |
| Dr. Lal Path Labs Limited | 0.65% | 1.79% |
| Himadri Speciality Chemical Limited | 0.61% | 1.45% |
| Manappuram Finance Limited | 0.51% | 1.91% |
| Tata Elxsi Limited | 0.40% | 1.58% |
| KPIT Technologies Limited | 0.25% | 1.06% |
| Natco Pharma Limited | 0.02% | 0.93% |
Sectors and company size
| UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund | Axis Nifty Smallcap 50 Index Fund | |
|---|---|---|
| Large companies | 11.7% | — |
| Mid companies | 62.8% | 6.8% |
| Small companies | 25.3% | 91.2% |
| Top 10 holdings | 33.3% | 34.4% |
| Largest sector | Pharmaceuticals & Biotechnology 18% | Pharmaceuticals & Biotechnology 16% |